Form 4 for MRK Merck & Co.
Accepted 2022-11-01 00:00:00 ET · period of report 2022-10-28 · accession 0001127602-22-024599 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-01 | 2022-10-28 | MRK | Oosthuizen Johannes Jacobus | Pres, U.S. Market | S - Sale+OE | $100.21 | -3,633 | 10.9K | -25% | -$364.1K |
| D | 2022-11-01 | 2022-10-30 | MRK | Oosthuizen Johannes Jacobus | Pres, U.S. Market | F - Tax | $100.77 | -450 | 11.3K | -4% | -$45.3K |
| D | 2022-11-01 | 2022-10-30 | MRK | Oosthuizen Johannes Jacobus | Pres, U.S. Market | M - OptEx | $100.77 | +913 | 11.8K | +8% | +$92.0K |
| D | 2022-11-01 | 2022-10-30 | MRK | Oosthuizen Johannes Jacobus | Pres, U.S. Market | M - OptEx | $0.00 | -913 | 915 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-28 | S | D | 3,633 | $100.21 | 10,880.88 | D | — | — | |
| 2 | Common | Common Stock | 2022-10-30 | F | D | 450 | $100.77 | 11,343.88 | D | — | — | (F1) Holdings include shares acquired in dividend reinvestment transactions. |
| 3 | Common | Common Stock | 2022-10-30 | M | A | 913 | $100.77 | 11,793.88 | D | — | — | |
| 4 | Derivative | Restricted Stock Unit | 2022-10-30 | M | D | 913 | $0.00 | 915 | D | — · 2021-10-30 to 2023-10-30 | 913 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. (F3) These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 10/30/2021, 10/30/2022 and 10/30/2023. |